Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 93573

AbstractCase ReportDiscussionConclusionKey MessageReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Case report
Year : 2011 | Month : June | Volume : 5 | Issue : 3 | Page : 637 - 639 Full Version

Aplastic anaemia complicating systemic lupus erythematosus (SLE) at presentation – A clinical vignette and review of literature


Published: June 1, 2011 | DOI: https://doi.org/10.7860/JCDR/2011/.1349
WESLEY JOSE, ATHIRA UNNIKRISHNAN, PALANIAPPAN MUTHU, KISHORE KUMAR, KEECHILAT PAVITHRAN

Department of Medical Oncology and Hematology, Cancer Institute, Amrita Institute of Medical Sciences, Ponekkara PO, Kochi, Kerala, India.

Correspondence Address :
Wesley M Jose
Department of Medical Oncology and Hematology
Cancer Institute, Amrita Institute of Medical Sciences
Ponekkara P.O. - 41, Kochi, Kerala, India.
Tel.: (+ 91) 484 4003020 – ext 3029
E-mail: wesleymjose@aims.amrita.edu

Abstract

Context : Systemic lupus erythematosus (SLE) is a common disease with myriad presentation. Aplastic anaemia is occasionally associated with this disorder; however, a simultaneous diagnosis of aplastic anaemia with SLE on presentation is unusual.

Case Report: We present here, probably the first reported case of simultaneous presentation of aplastic anaemia with florid features of SLE.

Keywords

Anaemia, Aplastic; Lupus Erythematosus, Systemic; Hydroxycorticosteroids

The haematological manifestations of systemic lupus erythematosus (SLE) commonly include anaemia(often autoimmune haemolytic anaemia), leucopaenia (usually lymphopaenia), thrombocytopaenia, recurrent arterial and venous thrombosis very often associated with anti-phospholipid antibodies (APLA). Pancytopaenia however, is relatively a rare occurrence. Pancytopaenia in SLE is more often attributed to the immune mediated peripheral destruction of the cells, rather than their underproduction in the marrow. Thus, aplastic anaemia is an extremely rare complication of SLE. Acquired aplastic anaemia remains a devastating and frustrating disease, from which a proportion of patients still die as a result of failure of support measures . Its pathogenesis remains a mystery. There are about 19 reported cases in the world literature. In most of these cases, the presentation of aplastic anaemia varied between one year prior to nine years after the diagnosis of SLE. There are however no reported cases of patients with aplastic anaemia and florid SLE at presentation. We report here, the first such case of aplastic anaemia presenting simultaneously with the classical features of SLE at onset in a 17 years old Indian female.

Case Report

A 17-year-old girl presented with the complaints of progressive breathlessness and abdominal distension, which was associated with intermittent fever of three weeks duration. On examination, she had moderate pallor, icterus, right-sided moderate pleural effusion, tense ascites and bilateral pitting pedal oedema. She had tachypnoea and tachycardia at rest, with a blood pressure of 150/100 mmHg. She had facial acne and abdominal striae. Ultrasonography (USG) of the abdomen showed mild splenomegaly. The investigations revealed pancytopaenia (haemoglobin 8.76 gram %; white blood cell count 1.13 x 103/uL; polymorphs 50%, lymphocytes 23%, monocytes 26%, eosinophils 1%; platelets 5600/cumm), direct hyperbilirubinaemia (total bilirubin 6.4 mg/dl, direct 3.5 mg/dl), mild transaminasaemia (aspartate aminotranferase [AST] – 140 IU/L; alanine aminotransferase [ALT] – 84 IU/L) and normal alkaline phosphatase (95 IU/L) levels. She had renal failure (blood urea110.8 mg/dl, creatinine 2.27 mg/dl). Her pleural and peritoneal effusion was found to be exudative. She had moderate proteinuria (684 mg/24 hours). Her corrected reticulocyte count was 0.82 %. There was no evidence of haemolysis, as she showed normal serum haptoglobin levels and a negative Coomb’s test. The bone marrow aspiration and trephine showed a hypocellular marrow with normal reticulin and few lymphoid aggregates. An initial diagnosis of aplastic anaemia was made, based on the International Aplastic Anemia Study Group criteria. She fulfilled the criteria with platelet counts < 20000/cumm and a corrected reticulocyte count of < 1%, along with a bone marrow cellularity of < 25%.

Owing to her multi-system involvement with poly-serositis, proteinuria and hepatitis, an autoimmune aetiology was considered. Her antinuclear antibody (ANA) was positive (1.11) and she had high titers of anti-double stranded DNA (anti-Ds DNA) of 1341 IU/l. She had mildly increased APLA antibodies (immunoglobulin G [IgG] 15.25 GPL units/ml and immunoglobulin M [IgM] 48.51 GPL units/ml), with normal anti Jo, anti-Scl-70, anti-Ro, anti-SS-A, anti-SS-B, anti-RNP and anti-Sm antibodies. Her complement levels were marginally low (C3 – 60.4 mg/dl and C4 – 18.8 mg/dl). A percutaneous renal biopsy was done, which revealed World Health Organization (WHO) class IIB Lupus nephritis – mesangioproliferative glomerulonephritis (MPGN). In view of her polyserositis, renal failure, pancytopaenia, positive ANA, and high anti Ds DNA, a diagnosis of systemic lupus erythematosus with aplastic anaemia was made. The likelihood of SLE induced pancytopaenia was considered to be unlikely, as it is usually not as severe as it was found in our patient.

She was treated with high dose Dexamethasone for four days. The patient had a dramatic improvement in her general condition after receiving steroids. She was discharged on oral Prednisolone 60 mg/day and Danazol 6 mg/day. Now, after 18 months, she is only on oral low dose Prednisolone 2.5 mg/day. Her parameters have normalized (creatinine 0.8 mg/dl, antiDs DNA 29 IU/L, complement C3 – 134 mg/dl, C4 – 43.8 mg/dl; haemoglobin 13.2 gram %, WBC count 8.67 x 103/ uL, polymorphs 61% lymphocytes 31%monocytes 4% eosinophils 4%, platelets 28,20,00/cumm). She is in complete remission and on regular follow up.

Discussion

The haematological manifestations of SLE typically include anaemia of chronic disease, lymphopaenia, immune thrombocytopaenic purpura, autoimmune haemolytic anaemia. These features may occur in up to 59% of the patients. However, the occurrence of pancytopaenia, myelofibrosis and aplastic anaemia is an extremely rare complication of SLE. There are 19 such reported cases in the world literature. Among the 20 reported cases, including ours, which have been reviewed here (Table/Fig 1), a female preponderance was found, with more than 80% of the patients being females and the age group varied between five months to 74 years, with mean age of 27.4 years. In most of the cases, aplastic anaemia either preceded the diagnosis of SLE, or developed later during the course of the illness. Chute et al.(1) described two cases, one of a 35 year old female and another, a 33-year old Hispanic male, who presented with aplastic anaemia as the sole presentation and after a period of 3 and 12 months respectively, developed the features of SLE. In the remaining cases, the time of the onset of aplastic anaemia varied between 1 yr before the diagnosis of SLE, up to 9 years after the diagnosis. To the best of our knowledge, ours is the first case which describes the occurrence of aplastic anaemia at presentation with the classical symptoms of SLE.

The therapy for immune-mediated dysfunction commonly includes pulse glucocorticoids alone or in combination with pulse cyclophosphamide. However, for those patients with an aggressive, life threatening or refractory disease, experimental therapies such as plasmapheresis or intravenous immunoglobulin may be used as adjuncts for their management. All the reported patients showed a complete response to the immunosuppressants. Eightpatients showed a good response to the high dose steroids and the remaining patients were treated with cyclophosphamide or cyclosporine or plasmapheresis. Of the eight patients who were treated with steroids, only three of them had received courses of steroids prior to the diagnosis of aplastic anaemia. All the other patients were on regular steroids when they developed aplastic anaemia. In this group, two patients succumbed to opportunistic infections. Wolach et al.(2) reported the first case of a baby who was born to an SLE mother. The infant presented with severe anaemia and with a circumscribed, reticular, macular rash on the face and neck at five months of age. A skin lesion biopsy revealed epidermic hyperkeratosis, hydropic degeneration of the basal layer, and the deposition of the immunoglobulins and the granular C1q at the dermoepidermal junction. Ro/SS-A antibodies were present in the infant, who showed good response to the steroids initially. The infant succumbed to infections at the age of 16 months. Pavithran et al.(3) reported the other case of a 32-year-old female who was initially diagnosed to have immune thrombocytopenic purpura (ITP) and was managed on this basis for 18 months. She later developed progressive pancytopaenia, polyarthritis and extensive rashes, which on further investigation, was proved to be SLE with aplastic anaemia. She also died due to fulminant infections.

The aplastic anaemia in SLE responds well to immunosuppressive therapy and has a relatively better prognosis, as compared to other causes of aplastic anaemia. The aplastic anaemia in SLE is likely to be immune mediated, considering its good response to immunosuppressive therapy.

The hypothesis of bone marrow aplasia, it being autoimmune in nature, is supported experimentally by some of the studies. Brooks et al.(4) demonstrated that the IgG complement-dependent antibody which was obtained from the patient’s disease-phase serum butnot from the remission-phase serum, suppressed the growth of the granulocyte-macrophage progenitor cells from the bone marrow of normal donors in vitro. Therapy with plasmapheresis and immunosuppression resulted in a lasting remission in their patient. Roffe et al.(5) postulated that the marrow aplasia might have been an autoimmune cellular process, as they demonstrated that bone marrow cultures showed the inhibition of erythropoiesis when they were incubated with acute and remission serum. But either serum did not affect the myeloid colony growth. Marques et al.(6) also did similar bone marrow culture studies, but they demonstrated a marked suppression of both haematopoiesis and myelopoiesis when various titers of the patient’s plasma were included in the culture media. The control plasma produced no inhibition. Sumimoto et al.(7) demonstrated increased numbers of CD8 cells in the marrow and suggested that the aplastic anaemia was caused due to a cell mediated process with the CD 8 cell mediated suppression of the bone marrow(8)(9)(10).

In our case, we did not do any in-vitro studies to prove the suppression of haematopoiesis on the stem cell or progenitor cell level due to the lack of availability of such tests locally. This would be helpful in definitively proving aplasia in this patient; however, we believe that the occurrence of the features which are classically diagnostic of aplastic anaemia with SLE in a patient who was absolutely asymptomatic three weeks prior, is significant enough to prove the association between SLE and aplastic anaemia.

Conclusion

We present a case of SLE with aplastic anaemia at presentation and this, to the best of our knowledge, is the first case which has been reported in the world literature. The diagnosis was not difficult due to the multi-system involvement, but it clearly suggests a need to look out for the autoimmune aetiology in every case of aplastic anaemia and the necessity to do a bone marrow examination in all cases of SLE with pancytopaenia, especially because aplastic anaemia in SLE has a higher chance of going into complete remission with properly tailored immunosuppressant therapy.

Key Message

It is necessary to look out for autoimmune aetiology in every case of aplastic anaemia and to prompt a bone marrow examination in all the cases of SLE with pancytopenia.

References

1.
Chute JP, Hoffmeister K, Cotelingam J, Davis TA, Frame JN, Jamieson T. Aplastic anemia as the sole presentation of systemic lupus erythematosus. Am J Hematol. 1996;51(3):237-9.
2.
Wolach B, Choc L, Pomeranz A, Ben Ari Y, Douer D, Metzker A. Aplastic anemia in neonatal lupus erythematosus. Am J Dis Child. 1993;147(9):941-4.
3.
Pavithran K, Raji NL, Thomas M. Aplastic anemia complicating systemic lupus erythematosus--report of a case and review of the literature. Rheumatol Int. 2002;22(6):253-5.
4.
Brooks BJ Jr, Broxmeyer HE, Bryan CF, Leech SH. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med. 1984;144(7):1474-7.
5.
Roffe C, Cahill MR, Samanta A, Bricknell S, Durrant ST. Aplastic anemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol. 1991;30(4):301-4.
6.
Marqués JA, Rhim H, Distenfeld A. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus. P R Health Sci J. 1995;14(4):293-6.
7.
Sumimoto S, Kawai M, Kasajima Y, Hamamoto T. Aplastic anemia associated with systemic lupus erythematosus. Am J Hematol. 1991;38(4):329-31.
8.
Fitchen JJ, Cline MJ, Saxon A, Golde DW. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Am J Med. 1979;66(3):537-42.
9.
Abdou NI, Lindsley HB, Pollock A, Stechschulte DJ, Wood G. Plasmapheresis in active systemic lupus erythematosus: effects on clinical, serum, and cellular abnormalities. Case report. Clin Immunol Immunopathol. 1981;19(1):44-54.
10.
Walport MJ, Hubbard WN, Hughes GR. Reversal of aplastic anemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed). 1982;285(6344):769-70.
11.
Stricker RB, Shuman MA. Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients. Am J Hematol. 1984;17(2):193-201.
12.
Winkler A, Jackson RW, Kay DS, Mitchell E, Carmignani S, Sharp GC. High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia. Arthritis Rheum. 1988;31(5):693-4.
13.
Bailey FA, Lilly M, Bertoli LF, Ball GV. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum. 1989;32(7):901-5.
14.
Hinterberger-Fischer M, Höcker P, Lechner K, Seewann H, Hinterberger W. Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Haematol. 1989;43(2):136-42.
15.
Tagoe C, Shah A, Yee H, Belmont HM. Aplastic anemia in systemic lupus erythematosus: a distinct presentation of acquired aplastic anemia? J Clin Rheumatol. 2001;7(6):377-83.
16.
Singh NP, Prakash A, Garg D, Makhija A, Pathania A, Prakash N et al. Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine Rheumatol Int. 2004;24(1):40-2.

Tables and Figures
[Table / Fig - 1]
DOI and Others

JCDR/2011/1349

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com